Abstract:We are investigating basic questions like why do Foxp3+ T-regulatory (Treg) cells have at least 3 nuclear complexes involving Hdac1 and Hdac2 (CoREST, Sin3, NuRD), and how can the inhibitory effects of Foxp3+ Tregs on host anti-tumor immune responses be targeted therapeutically? Here, we report on the immune functions of chromodomain-helicase-DNA-binding protein 4 (Chd4), a key enzyme of the nucleosome remodeling and deacetylase complex (NuRD) complex. TCGA analysis showed increased Chd4 expression and Foxp3+ Tregs within lung tumors, leading us to assess the effects of conditional gene deletion within Foxp3+ murine Tregs. Chd4 knockout led to systemic autoimmunity and death of mice within 3 weeks of life and RNAseq studies showed Chd4 loss led to derepression of ~1400 genes and repression of >700 further genes resulting in a Treg signature markedly different from conditional deletion of Hdac1, Hdac2 or Mbd2 in Treg cells. Chd4 is an intrinsically disordered therapeutic target without a defined structure outside its physiological cell environment. To date, no specific inhibitors targeting Chd4 have been developed. We have identified Ch41, a novel and potent inhibitor of Chd4, using a novel cellular target engagement platform. Transcriptomic and mass-spec investigations showed that Ch41 impaired thymic Treg function and iTreg development, led to decreased CNS2 demethylation within the Foxp3 locus, and significantly impaired growth of lung tumors and hepatocellular carcinomas in immunocompetent but not in immunodeficient C57BL/6 mice (p<0.01). Following Chd4 inhibitor therapy, intratumoral conventional T cells had increased activation and cytokine production (IL-2, IFN-g) compared to intratumoral T cells in control tumor-bearing mice but, perhaps unexpectedly, treated mice did not show histologic or biochemical evidence of autoimmunity. We conclude that while tumor associated Tregs have unique properties that include their increased suppressive activity compared to non-tumor associated Treg cells, they are also more susceptible than the latter and conventional T cells to newly developed therapeutic interventions, including targeting of the Chd4 chromodomain of the NuRD complex. Citation Format: Wayne W. Hancock, Liqing Wang, Martina Minisini, Eros di Giorgio, Ivan Babic, Elmar Nurmemmedov. Unexpected role of the NuRD component, Chd4, in Foxp3+ Treg cells and its relevance to tumor immunotherapy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 2655.

CHD4 orchestrates the symphony of T and B lymphocytes development and a good mediator in preventing from autoimmune disease

[Benign paroxysmal postural vertigo: basis and its therapy in clinical practice].

MLL4 Prepares the Enhancer Landscape for Foxp3 Induction Via Chromatin Looping

Chromatin gatekeeper and modifier CHD proteins in development, and in autism and other neurological disorders

Percutaneous silicon catheter insertion into the inferior vena cava, following percutaneous nephrostomy exchange.

CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axis.

CHD4 Mediates Proliferation and Migration of Non-Small Cell Lung Cancer Via the RhoA/ROCK Pathway by Regulating PHF5A

Chd4 is Associated with Poor Prognosis of Non- Small Cell Lung Cancer Patients Through Promoting Tumor Cell Proliferation

CHD4 Promotes Acquired Chemoresistance and Tumor Progression by Activating the MEK/ERK Axis

The Adrenergic-Cholinergic Imbalance Hypothesis of Depression: A Review and a Perspective

Molecular Control of Follicular Helper T cell Development and Differentiation

CHD4 Interacts With TBX5 to Maintain the Gene Regulatory Network of Postnatal Atrial Cardiomyocytes

Genomic transcription factor binding site selection is edited by the chromatin remodeling factor CHD4

CHD4 Promotes Breast Cancer Progression As a Coactivator of Hypoxia-Inducible Factors.

Collective mind in organizations: Heedful interrelating on flight decks.

Abstract 2655: Unexpected role of the NuRD component, Chd4, in Foxp3+ Treg cells and its relevance to tumor immunotherapy

CaMK4 controls follicular helper T cell expansion and function during normal and autoimmune T-dependent B cell responses

On psychoanalytic supervisor competencies, the persistent paradox without parallel in psychoanalytic education, and dreaming of an evidence-based psychoanalytic supervision.

Chromodomain Helicase DNA-Binding Proteins in Stem Cells and Human Developmental Diseases

CHD4 acts as a prognostic factor and drives radioresistance in HPV negative HNSCC

CBX4 Promotes Antitumor Immunity by Suppressing Pdcd1 Expression in T Cells.